Tirzepatide is a dual GIP/GLP-1 receptor agonist that generally produces greater weight loss than semaglutide in head-to-head trials
Neurological manifestations include developmental delay, psychomotor retardation, behavioral abnormalities, ataxia, peripheral neuropathy, and seizures
Signs include: Hives or widespread rash beyond the injection site Swelling of face, lips, tongue, or throat Difficulty breathing or wheezing Rapid heartbeat Feeling faint or losing consciousness These symptoms require immediate medical attention
Inject gently: Insert the needle into the peptide vial, angle to let the solvent run down the inner wall slowly, avoid direct powder blasts that cause foaming or denaturation
Maximizing your energy and stamina could make your workouts more effective and enjoyable
For beginners, the honest summary is that BPC-157 and TB-500 are two well-studied research peptides with complementary mechanisms and a popular nickname, not a clinically validated combination